These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3348855

  • 1. Catechol-o-methyl transferase activity in the human term placenta.
    Barnea ER, MacLusky NJ, DeCherney AH, Naftolin F.
    Am J Perinatol; 1988 Apr; 5(2):121-7. PubMed ID: 3348855
    [Abstract] [Full Text] [Related]

  • 2. Monoamine oxidase activity in the term human placenta.
    Barnea ER, MacLusky NJ, DeCherney AH, Naftolin F.
    Am J Perinatol; 1986 Jul; 3(3):219-24. PubMed ID: 3718643
    [Abstract] [Full Text] [Related]

  • 3. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.
    Zhu BT, Patel UK, Cai MX, Conney AH.
    Drug Metab Dispos; 2000 Sep; 28(9):1024-30. PubMed ID: 10950844
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
    Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD.
    Cancer Res; 1997 Dec 15; 57(24):5493-7. PubMed ID: 9407957
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T, Machado R, Rocha JF, Fernandes-Lopes C, Costa R, Torrão L, Loureiro AI, Falcão A, Vaz-da-Silva M, Wright L, Almeida L, Soares-da-Silva P.
    Clin Ther; 2009 Oct 15; 31(10):2258-71. PubMed ID: 19922897
    [Abstract] [Full Text] [Related]

  • 7. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.
    Pharmacogenet Genomics; 2008 Sep 15; 18(9):815-21. PubMed ID: 18698234
    [Abstract] [Full Text] [Related]

  • 8. [Serum unconjugated 2-hydroxyestrone and erythrocyte catechol-O-methyltransferase activity in pregnancy toxemia].
    Fujino T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct 15; 35(10):1767-76. PubMed ID: 6631152
    [Abstract] [Full Text] [Related]

  • 9. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
    Goodman JE, Lavigne JA, Hengstler JG, Tanner B, Helzlsouer KJ, Yager JD.
    Cancer Epidemiol Biomarkers Prev; 2000 Dec 15; 9(12):1373-6. PubMed ID: 11142424
    [Abstract] [Full Text] [Related]

  • 10. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
    Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF.
    Cancer Res; 2001 Sep 15; 61(18):6716-22. PubMed ID: 11559542
    [Abstract] [Full Text] [Related]

  • 11. Estrogen hydroxylase activity in the human placenta at term.
    Barnea ER, MacLusky NJ, Purdy R, Naftolin F.
    J Steroid Biochem; 1988 Aug 15; 31(2):253-5. PubMed ID: 3404995
    [Abstract] [Full Text] [Related]

  • 12. O-methylation of catechol estrogens by human placental catechol-o-methyltransferase: interindividual differences in sensitivity to heat inactivation and to inhibition by dietary polyphenols.
    Zhu BT, Wu KY, Wang P, Cai MX, Conney AH.
    Drug Metab Dispos; 2010 Oct 15; 38(10):1892-9. PubMed ID: 20606002
    [Abstract] [Full Text] [Related]

  • 13. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase.
    Nagai M, Conney AH, Zhu BT.
    Drug Metab Dispos; 2004 May 15; 32(5):497-504. PubMed ID: 15100171
    [Abstract] [Full Text] [Related]

  • 14. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW, Yager JD.
    Cancer Res; 2001 Oct 15; 61(20):7488-94. PubMed ID: 11606384
    [Abstract] [Full Text] [Related]

  • 15. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
    Zhao WQ, Latinwo L, Liu XX, Lee ES, Lamango N, Charlton CG.
    Exp Neurol; 2001 Sep 15; 171(1):127-38. PubMed ID: 11520127
    [Abstract] [Full Text] [Related]

  • 16. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
    Butterworth M, Lau SS, Monks TJ.
    Drug Metab Dispos; 1996 May 15; 24(5):588-94. PubMed ID: 8723741
    [Abstract] [Full Text] [Related]

  • 17. Pharmacogenetics of catechol-O-methyltransferase: frequency of low activity allele in a Ghanaian population.
    Ameyaw MM, Syvänen AC, Ulmanen I, Ofori-Adjei D, McLeod HL.
    Hum Mutat; 2000 Nov 15; 16(5):445-6. PubMed ID: 11058906
    [Abstract] [Full Text] [Related]

  • 18. Catechol O-methyltransferase activity in the human placenta and liver.
    Burba JV.
    Can J Physiol Pharmacol; 1979 Feb 15; 57(2):213-6. PubMed ID: 546488
    [Abstract] [Full Text] [Related]

  • 19. Suppression of catechol-O-methyltransferase activity through blunting of alpha2-adrenoceptor can explain hypertension in Dahl salt-sensitive rats.
    Hirano Y, Tsunoda M, Shimosawa T, Matsui H, Fujita T, Funatsu T.
    Hypertens Res; 2007 Mar 15; 30(3):269-78. PubMed ID: 17510509
    [Abstract] [Full Text] [Related]

  • 20. Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter.
    Percy E, Kaye DM, Lambert GW, Gruskin S, Esler MD, Du XJ.
    Br J Pharmacol; 1999 Oct 15; 128(3):774-80. PubMed ID: 10516661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.